Want to join the conversation?
$ABBV's gross margin for 1Q16 fell to 77% from 81% last year. This was primarily due to higher amortization expense related to amortization of intangible assets and fair market value step-up for inventory in connection with acquisition of Pharmacyclics. Gross margin also included $39MM impairment charge of intangible asset in 1Q16.
$TXMD flying high.. anyone here to catch..?
$CMG crashing. There seems to be nothing good to read about this company.
Impressed with $AMZN’s latest grocery ambitions. The new Amazon Go convenience store, is an absolute game changer.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$